Product Name: Human PSGL1 Antibody (Neihulizumab, Research Use)
Catalog Number: NBR-0078
Target Name: PSGL1
Trade Name: Neihulizumab
Antibody Drug Description: Neihulizumab is a humanized, agonistic monoclonal antibody against P selectin glycoprotein ligand-1 (PSGL-1; SELPLG; CD162), with potential immunosuppressive activity. Appearance: Transparent Liquid
Molecular Weight: ~150kDa
CAS：N/A
Solubility: Water; PBS, TBS Buffer etc.
Expression System: CHO Expressed
Isotype of Ab: Ab. Isotype - IgG

  Gene Name: PSGL1
Synonyms: SELPLG; CD162
Target Description: SELPLG (Selectin P Ligand) is a Protein Coding gene. Diseases associated with SELPLG include Human Granulocytic Anaplasmosis and Ehrlichiosis. Among its related pathways are Response to elevated platelet cytosolic Ca2+ and Complement cascade. Gene Ontology (GO) annotations related to this gene include signaling receptor binding.
Ensembl: ENSG00000110876
Uniprot: Q14242